Go to
JCI Insight
Citations to this article
D Praticò, … , F Violi, G A FitzGerald
Published October 15, 1997
Citation Information: J Clin Invest. 1997;100(8):2028-2034. https://doi.org/10.1172/JCI119735.
Citation Information: J Clin Invest. 1997;100(8):2028-2034. https://doi.org/10.1172/JCI119735.
Abstract
Research Article
Authors
D Praticò, L Iuliano, A Mauriello, L Spagnoli, J A Lawson, J Rokach, J Maclouf, F Violi, G A FitzGerald
Total citations by year
Citation information
Citations to this article (262)
| Title and authors | Publication | Year |
|---|---|---|
|
Role of Reactive Oxygen Species in Collagen-Induced Platelet Activation and the Protective Effects of Antioxidants
Han JY, Utsumi H, Chung HY |
Antioxidants | 2025 |
|
Preventive Therapies in Peripheral Arterial Disease
Shah AJ, Pavlatos N, Kalra DK |
Biomedicines | 2023 |
|
Involvement of Fatty Acids and Their Metabolites in the Development of Inflammation in Atherosclerosis.
Kotlyarov S, Kotlyarova A |
International journal of molecular sciences | 2022 |
|
Antioxidant properties of anthocyanins and their mechanism of action in atherosclerosis
C Garcia, CN Blesso |
Free radical biology & medicine | 2021 |
|
ROS in Platelet Biology: Functional Aspects and Methodological Insights
E Masselli, G Pozzi, M Vaccarezza, P Mirandola, D Galli, M Vitale, C Carubbi, G Gobbi |
International journal of molecular sciences | 2020 |
|
Lipid Peroxidation in Atherosclerotic Cardiovascular Diseases
E Gianazza, M Brioschi, AM Fernandez, F Casalnuovo, A Altomare, G Aldini, C Banfi |
Antioxidants & Redox Signaling | 2020 |
|
Biochemical basis and metabolic interplay of redox regulation
L Zhang, X Wang, R Cueto, C Effi, Y Zhang, H Tan, X Qin, Y Ji, X Yang, H Wang |
Redox Biology | 2019 |
|
Higher plasma levels of F 2 -isoprostanes are associated with slower psychomotor speed in healthy older adults
DA Camfield, K Nolidin, K Savage, J Timmer, K Croft, MT Fard, T Simpson, L Downey, A Scholey, A Pipingas, S Deleuil, C Stough |
Free Radical Research | 2019 |
|
Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque
R Carnevale, C Nocella, V Petrozza, V Cammisotto, L Pacini, V Sorrentino, O Martinelli, L Irace, S Sciarretta, G Frati, D Pastori, F Violi |
Scientific Reports | 2018 |
|
Oxidant-specific biomarkers of oxidative stress. Association with atherosclerosis and implication for antioxidant effects
E Niki |
Free radical biology & medicine | 2018 |
|
Impaired verbal episodic memory in healthy older adults is marked by increased F 2 -Isoprostanes
LA Downey, T Simpson, J Timmer, K Nolidin, K Croft, KA Wesnes, A Scholey, S Deleuil, C Stough |
Prostaglandins, leukotrienes, and essential fatty acids | 2018 |
|
Unraveling mechanisms of toxicant-induced oxidative stress in cardiovascular disease
TR Dugas |
Current Opinion in Toxicology | 2018 |
|
F2-isoprostanes affect macrophage migration and CSF-1 signalling
JM Proudfoot, MW Murrey, S McLean, EL Greenland, AE Barden, KD Croft, JM Galano, T Durand, TA Mori, FJ Pixley |
Free radical biology & medicine | 2018 |
|
Effect of low levels of lipid oxidation on the curvature, dynamics, and permeability of lipid bilayers and their interactions with cationic nanoparticles
H Lee, N Malmstadt |
Journal of Physics D: Applied Physics | 2018 |
|
Comprehensive Cardiovascular Medicine in the Primary Care Setting
PP Toth, CP Cannon |
2018 | |
|
Endoplasmic Reticulum Stress, NRF2 Signalling and Cardiovascular Diseases in a Nutshell
C Mozzini, L Cominacini, U Garbin, AM Pasini |
Current Atherosclerosis Reports | 2017 |
|
ATHEROTHROMBOSIS AND OXIDATIVE STRESS: MECHANISMS AND MANAGEMENT IN ELDERLY
F Violi, L Loffredo, R Carnevale, P Pignatelli, D Pastori |
Antioxidants & Redox Signaling | 2017 |
|
The Antioxidant Effect of Exercise: A Systematic Review and Meta-Analysis
CV de Sousa, MM Sales, TS Rosa, JE Lewis, RV de Andrade, HG Simões |
Sports Medicine | 2016 |
|
Addition of Cleaved Tail Fragments during Lipid Oxidation Stabilizes Membrane Permeability Behavior
KA Runas, SJ Acharya, JJ Schmidt, N Malmstadt |
Langmuir | 2016 |
|
Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review
KP Poulianiti, A Kaltsatou, GI Mitrou, AZ Jamurtas, Y Koutedakis, M Maridaki, I Stefanidis, GK Sakkas, C Karatzaferi |
Oxidative medicine and cellular longevity | 2016 |
|
Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients
L Ménégaut, D Masson, N Abello, D Denimal, C Truntzer, P Ducoroy, L Lagrost, JP de Barros, A Athias, JM Petit, L Martin, E Steinmetz, B Kretz |
Atherosclerosis | 2016 |
|
Biomarkers in Cardiovascular Disease
A Akyüz |
Biomarkers in Cardiovascular Disease | 2016 |
|
Impact of commonly prescribed exercise interventions on platelet activation in physically inactive and overweight men
A Haynes, MD Linden, E Robey, GF Watts, H Barrett, LH Naylor, DJ Green |
Physiological Reports | 2016 |
|
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
S Tangvarasittichai |
World journal of diabetes | 2015 |
|
Prostanoids and NSAIDs in Cardiovascular Biology and Disease
BB Weksler |
Current Atherosclerosis Reports | 2015 |
|
Low levels of lipid oxidation radically increase the passive permeability of lipid bilayers
KA Runas, N Malmstadt |
Soft Matter | 2015 |
|
Habitual high intake of fatty fish is related to lower levels of F2-isoprostane in healthy women
P Hansson, L Barregård, M Halltorp, S Sibthorpe, C Svelander, AS Sandberg, S Basu, MR Hoppe, L Hulthén |
Nutrition | 2015 |
|
Urinary biomarkers of oxidative and nitrosative stress and the risk for incident stroke: A Nested case-control study from a community-based cohort
HJ Lin, ST Chen, HY Wu, HC Hsu, MF Chen, YT Lee, KY Wu, KL Chien |
International Journal of Cardiology | 2015 |
|
Carotenoids from Marine Microalgae: A Valuable Natural Source for the Prevention of Chronic Diseases
M Raposo, A Morais, R Morais |
Marine drugs | 2015 |
|
Studies on Experimental Toxicology and Pharmacology
SM Roberts, JP Kehrer, LO Klotz |
2015 | |
|
Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A 2 receptor activation: Pathophysiology of isoprostanes in the cardiovascular system
J Bauer, A Ripperger, S Frantz, S Ergün, E Schwedhelm, RA Benndorf |
British Journal of Pharmacology | 2014 |
|
Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation
V Capra, M Bäck, DJ Angiolillo, M Cattaneo, KS Sakariassen |
Journal of Thrombosis and Haemostasis | 2014 |
|
Liquid chromatography–tandem mass spectrometry for the analysis of eicosanoids and related lipids in human biological matrices: A review
L Kortz, J Dorow, U Ceglarek |
Journal of Chromatography B | 2014 |
|
Do Oxidized Polyunsaturated Fatty Acids Affect Endoplasmic Reticulum Stress-Induced Apoptosis in Human Carotid Plaques?
U Garbin, C Stranieri, A Pasini, E Baggio, G Lipari, E Solani, C Mozzini, P Vallerio, L Cominacini, AF Pasini |
Antioxidants & Redox Signaling | 2014 |
|
Oxidized PLs and Vascular Inflammation
M Aldrovandi, VB O’Donnell |
Current Atherosclerosis Reports | 2013 |
|
Lipid peroxidation biomarkers for evaluating oxidative stress and assessing antioxidant capacity in vivo
Y Yoshida, A Umeno, M Shichiri |
Journal of Clinical Biochemistry and Nutrition | 2013 |
|
Biomarkers of oxidative damage are elevated among individuals with high cardiovascular risk: Refining subject selection strategies for antioxidant trials
RC Seet, AM Quek, EC Lim, B Halliwell |
Free Radical Research | 2013 |
|
Association between the C242T polymorphism of p22phox gene and ischemic stroke: A meta-analysis
L Gu, L Su, B Liang, N Tang, J Long, J Tan, Q Chen, J Xie, G Wu, Y Yan, G Huang, X Zu |
Journal of the Neurological Sciences | 2013 |
|
Changes in biomarkers and 24 hours blood pressure in hypertensive African Americans with the metabolic syndrome: comparison of amlodipine/olmesartan versus hydrochlorothiazide/losartan
N Merchant, ST Rahman, M Ahmad, JM Parrott, J Johnson, KC Ferdinand, BV Khan |
Journal of the American Society of Hypertension | 2013 |
|
Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro: Stored RBCs Accumulate Lipid Mediators
SL Spinelli, KL Lannan, AE Casey, A Croasdell, TM Curran, KF Henrichs, SJ Pollock, GA Milne, MA Refaai, CW Francis, RP Phipps, N Blumberg |
Transfusion | 2013 |
|
Singlet oxygen induced products of linoleates, 10- and 12-(Z,E)-hydroxyoctadecadienoic acids (HODE), can be potential biomarkers for early detection of type 2 diabetes
A Umeno, M Shichiri, N Ishida, Y Hashimoto, K Abe, M Kataoka, K Yoshino, Y Hagihara, N Aki, M Funaki, Y Asada, Y Yoshida |
PloS one | 2013 |
|
Singlet Oxygen Induced Products of Linoleates, 10- and 12-(Z,E)-Hydroxyoctadecadienoic Acids (HODE), Can Be Potential Biomarkers for Early Detection of Type 2 Diabetes
A Umeno, M Shichiri, N Ishida, Y Hashimoto, K Abe, M Kataoka, K Yoshino, Y Hagihara, N Aki, M Funaki, Y Asada, Y Yoshida, B Wagner |
PloS one | 2013 |
|
Relationship between inflammatory markers, oxidant–antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis
L Breda, DD Marzio, C Giannini, S Gaspari, M Nozzi, A Scarinci, F Chiarelli, A Mohn |
Clinical Research in Cardiology | 2012 |
|
The Relation between Carotid Plaque Echogenicity and Oxidative Stress Marker 8-iso-prostaglandin F2α
H Nassar, S Furukado, M Tanaka, K Miwa, S Okazaki, M Sakaguchi, H Mochizuki, K Kitagawa |
Ultrasound in Medicine & Biology | 2012 |
|
Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke : EICOSANOIDS AND THEIR DRUGS IN CVDS
V Capra, M Bäck, SS Barbieri, M Camera, E Tremoli, GE Rovati |
Medicinal Research Reviews | 2012 |
|
Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids?
U Garbin, E Baggio, C Stranieri, A Pasini, S Manfro, C Mozzini, P Vallerio, G Lipari, F Merigo, G Guidi, L Cominacini, AF Pasini |
Cardiovascular Research | 2012 |
|
Atherosclerosis: Treatment and Prevention
GP Shi, P Libby |
Atherosclerosis: Treatment and Prevention | 2012 |
|
Reactive Oxygen Species in Cardiovascular Disease
K Sugamura, JF Keaney |
Free radical biology & medicine | 2011 |
|
Oxidative Stress and Disease
I Paur, M Carlsen, B Halvorsen, R Blomhoff |
Herbal Medicine | 2011 |
|
Advances in Clinical Chemistry
M Mahler |
Advances in Clinical Chemistry Volume 54 | 2011 |
|
Pathways of cholesterol oxidation via non-enzymatic mechanisms
L Iuliano |
Chemistry and Physics of Lipids | 2011 |
|
The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome
D Monneret, R Tamisier, V Ducros, C Garrel, P Levy, JP Baguet, P Faure, JL Pépin |
Respiratory Physiology & Neurobiology | 2011 |
|
Desorption electrospray ionization mass spectrometry for lipid characterization and biological tissue imaging
LS Eberlin, CR Ferreira, AL Dill, DR Ifa, RG Cooks |
Biochimica et Biophysica Acta | 2011 |
|
Studies on Experimental Models
S Basu, L Wiklund |
2011 | |
|
Generation and Biological Activities of Oxidized Phospholipids
VN Bochkov, OV Oskolkova, KG Birukov, AL Levonen, CJ Binder, J Stöckl |
Antioxidants & Redox Signaling | 2010 |
|
Increased oxidative stress and altered substrate metabolism in obese children
SR Oliver, JS Rosa, GL Milne, AM Pontello, HL Borntrager, S Heydari, PR Galassetti |
International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity | 2010 |
|
Biomarkers for Antioxidant Defense and Oxidative Damage: Principles and Practical Applications
JD Brooks, BE Cox, KD Hardy, SC Sanchez, S Tourino, TH Koestner, JR Hyman-Howard, GL Milne |
Biomarkers for Antioxidant Defense and Oxidative Damage: Principles and Practical Applications | 2010 |
|
Desorption electrospray ionization imaging mass spectrometry of lipids in rat spinal cord
M Girod, Y Shi, JX Cheng, RG Cooks |
Journal of the American Society for Mass Spectrometry | 2010 |
|
Effects of V279F in the Lp-PLA2 gene on markers of oxidative stress and inflammation in Koreans
JK Paik, JS Chae, Y Jang, JY Kim, OY Kim, TS Jeong, SH Lee, JH Lee |
Clinica Chimica Acta | 2010 |
|
Mapping Lipid Alterations in Traumatically Injured Rat Spinal Cord by Desorption Electrospray Ionization Imaging Mass Spectrometry
M Girod, Y Shi, JX Cheng, RG Cooks |
Analytical Chemistry | 2010 |
|
Effects of Fenofibrate on Plasma Oxidized LDL and 8-Isoprostane In a Sub-Cohort of GOLDN Participants
Y Dong, BT Steffen, J Cao, AK Tsai, J Ordovas, R Straka, X Zhou, E Kabagambe, NQ Hanson, D Arnett, MY Tsai |
Atherosclerosis | 2010 |
|
Isoprostane, an "intermediate phenotype" for oxidative stress heritability, risk trait associations, and the influence of chromogranin B polymorphism
F Rao, K Zhang, S Khandrika, M Mahata, MM Fung, MG Ziegler, BK Rana, DT O'Connor |
Journal of the American College of Cardiology | 2010 |
|
Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation
WL Song, G Paschos, S Fries, MP Reilly, Y Yu, J Rokach, CT Chang, P Patel, JA Lawson, GA Fitzgerald |
The Journal of biological chemistry | 2009 |
|
Isoprostanes 8-iPF 2α -III: risk markers of premature rupture of fetal membranes?
S Kwiatkowski, A Torbé, B Dołęgowska, W Błogowski, R Czajka, D Chlubek, R Rzepka |
Biomarkers | 2009 |
|
Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque composition
T Cyrus, T Ding, D Praticò |
Atherosclerosis | 2009 |
|
F2-Isoprostanes as Novel Biomarkers for Type 2 Diabetes: a Review
S Kaviarasan, S Muniandy, R Qvist, IS Ismail |
Journal of Clinical Biochemistry and Nutrition | 2009 |
|
Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target
M Ali, M Madjid |
Future Cardiology | 2009 |
|
CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice
G An, T Miwa, WL Song, JA Lawson, DJ Rader, Y Zhang, WC Song |
Molecular Immunology | 2009 |
|
Mass spectrometric imaging of lipids using desorption electrospray ionization
AL Dill, DR Ifa, NE Manicke, Z Ouyang, RG Cooks |
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences | 2009 |
|
Lipidomic Analysis of Glycerolipid and Cholesteryl Ester Autooxidation Products
A Kuksis, JP Suomela, M Tarvainen, H Kallio |
Molecular Biotechnology | 2009 |
|
Vascular biology of eicosanoids and atherogenesis
D Praticò, JM Dogné |
Expert Review of Cardiovascular Therapy | 2009 |
|
Usefulness of Elevations in Serum Choline and Free F2-Isoprostane to Predict 30-Day Cardiovascular Outcomes in Patients With Acute Coronary Syndrome
RM LeLeiko, CS Vaccari, S Sola, N Merchant, SH Nagamia, M Thoenes, BV Khan |
The American Journal of Cardiology | 2009 |
|
Exposure to ambient levels of particles emitted by traffic worsens emphysema in mice
FD Lopes, TS Pinto, FM Arantes-Costa, HT Moriya, PJ Biselli, LF Ferraz, AJ Lichtenfels, PH Saldiva, T Mauad, MA Martins |
Environmental Research | 2009 |
|
Effect of rosuvastatin on concentrations of plasma lipids, urine and plasma oxidative stress markers, and plasma high-sensitivity C-reactive protein in hypercholesterolemic patients with and without type 2 diabetes mellitus: A 12-week, open-label, pilot study
G Yoshino, M Tanaka, S Nakano, T Matsumoto, M Kojima, E Murakami, T Morita |
Current Therapeutic Research | 2009 |
|
Novel Eicosapentaenoic Acid-derived F 3 -isoprostanes as Biomarkers of Lipid Peroxidation
WL Song, G Paschos, S Fries, MP Reilly, Y Yu, J Rokach, CT Chang, P Patel, JA Lawson, GA FitzGerald |
The Journal of biological chemistry | 2009 |
|
Lack of Evidence for Antiatherogenic Effects of Wheat Bran or Corn Bran in Apolipoprotein E-Knockout Mice
Z Zhao, Z Xu, K Le, N Azordegan, ND Riediger, MH Moghadasian |
Journal of Agricultural and Food Chemistry | 2009 |
|
Lipid Profiles of Canine Invasive Transitional Cell Carcinoma of the Urinary Bladder and Adjacent Normal Tissue by Desorption Electrospray Ionization Imaging Mass Spectrometry
AL Dill, DR Ifa, NE Manicke, AB Costa, JA Ramos-Vara, DW Knapp, RG Cooks |
Analytical Chemistry | 2009 |
|
Reply
J Bommer, T Heinrich, H Heidt, V Hafner, E Jenetzky, I Walter-Sack, G Mikus |
Nephrology Dialysis Transplantation | 2008 |
|
Obstructive sleep apnea: the new cardiovascular disease. Part I: obstructive sleep apnea and the pathogenesis of vascular disease
R Khayat, B Patt, D Hayes |
Heart Failure Reviews | 2008 |
|
Beyond Prostaglandins-Chemistry and Biology of Cyclic Oxygenated Metabolites Formed by Free-Radical Pathways from Polyunsaturated Fatty Acids
U Jahn, JM Galano, T Durand |
Angewandte Chemie International Edition | 2008 |
|
F2-Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications
S Basu |
Antioxidants & Redox Signaling | 2008 |
|
Jenseits von Prostaglandinen - Chemie und Biologie radikalisch gebildeter cyclischer oxygenierter Metabolite von mehrfach ungesättigten Fettsäuren
U Jahn, JM Galano, T Durand |
Angewandte Chemie | 2008 |
|
Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness
Y Cheung, K O, CW Woo, S Armstrong, YL Siow, P Chow, EW Cheung |
BMC Pediatrics | 2008 |
|
New techniques to detect oxidative stress markers: Mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stressin vivo
H Yin |
BioFactors | 2008 |
|
Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children
C Giannini, T Giorgis, A Scarinci, M Ciampani, ML Marcovecchio, F Chiarelli, A Mohn |
Atherosclerosis | 2008 |
|
Prostanoid and isoprostanoid pathways in atherogenesis
D Praticò |
Atherosclerosis | 2008 |
|
Stereoselective Synthesis of acis-1,2-Dialkylcyclopentane Building Block and Its Application in Isoprostane Synthesis (5-ent-F2c-IsoP)
P Elsner, P Jetter, K Brödner, G Helmchen |
European Journal of Organic Chemistry | 2008 |
|
The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans
B Ky, A Burke, S Tsimikas, ML Wolfe, MG Tadesse, PO Szapary, JL Witztum, GA FitzGerald, DJ Rader |
Journal of the American College of Cardiology | 2008 |
|
Increased isoprostane content in coronary plaques obtained from vulnerable patients
A Nishibe, Y Kijima, M Fukunaga, N Nishiwaki, T Sakai, Y Nakagawa, T Hata |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2008 |
|
Transdermal estradiol reduces F2α-isoprostane levels in postmenopausal women
C Hermenegildo, PJ Oviedo, A Laguna, MA García-Pérez, JJ Tarín, A Cano |
Menopause | 2008 |
|
Identifying the Changes in Gene Profiles Regulating the Amelioration of Age-Related Oxidative Damages in Kidney Tissue of Rats by the Intervention of Adult-Onset Calorie Restriction
J Chen, CN Velalar, R Ruan |
Rejuvenation Research | 2008 |
|
Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples
Y Yoshida, S Kodai, S Takemura, Y Minamiyama, E Niki |
Analytical Biochemistry | 2008 |
|
In Vivo Markers of Oxidative Stress and Therapeutic Interventions
S Tsimikas |
The American Journal of Cardiology | 2008 |
|
Reduced antioxidant capacity and diet-induced atherosclerosis in uncoupling protein-2-deficient mice
F Moukdar, J Robidoux, O Lyght, J Pi, KW Daniel, S Collins |
Journal of lipid research | 2008 |
|
Biomarkers related to aging in human populations
Eileen Crimmins, Sarinnapha Vasunilashorn, Jung Ki Kim, Dawn Alley |
Advances in Clinical Chemistry | 2008 |
|
Atherosclerosis and Oxidant Stress
JL Holtzman |
2008 | |
|
BIOMARKERS RELATED TO AGING IN HUMAN POPULATIONS
Crimmins E, Vasunilashorn S, Kim JK, Alley D |
Advances in Clinical Chemistry | 2008 |
|
Oxidized phospholipids: From molecular properties to disease
GO Fruhwirth, A Loidl, A Hermetter |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2007 |
|
Oxidative stress and endothelial dysfunction in vascular disease
S Pennathur, JW Heinecke |
Current Diabetes Reports | 2007 |
|
Biomarkers of Obesity and Subsequent Cardiovascular Events
S Musaad, EN Haynes |
Epidemiologic Reviews | 2007 |
|
Abnormal Tissue Doppler Images are Associated With Elevated Plasma Brain Natriuretic Peptide and Increased Oxidative Stress in Acute Kawasaki Disease
D Takeuchi, T Saji, S Takatsuki, M Fujiwara |
Circulation Journal | 2007 |
|
C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension
S Cottone, G Mulè, E Nardi, A Vadalà, MC Lorito, M Guarneri, R Arsena, A Palermo, G Cerasola |
Journal of Hypertension | 2007 |
|
BM-520, an original TXA2 modulator, inhibits the action of thromboxane A2 and 8-iso-prostaglandin F2α in vitro and in vivo on human and rodent platelets, and aortic vascular smooth muscles from rodents
S Rolin, J Hanson, C Vastersaegher, C Cherdon, D Pratico, B Masereel, JM Dogne |
Prostaglandins & Other Lipid Mediators | 2007 |
|
The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target
S Basu |
Scandinavian Journal of Food & Nutrition | 2007 |
|
Neurofurans, Novel Indices of Oxidant Stress Derived from Docosahexaenoic Acid
WL Song, JA Lawson, D Reilly, J Rokach, CT Chang, B Giasson, GA FitzGerald |
The Journal of biological chemistry | 2007 |
|
Fish Oil Increases Cholesterol Storage in White Adipose Tissue with Concomitant Decreases in Inflammation, Hepatic Steatosis, and Atherosclerosis in Mice
V Saraswathi, L Gao, JD Morrow, A Chait, KD Niswender, AH Hasty |
The Journal of nutrition | 2007 |
|
Does Glucose in Dialysis Fluid Protect Erythrocytes in Patients with Chronic Renal Failure?
B Dolegowska, J Stepniewska, K Ciechanowski, K Safranow, B Millo, J Bober, D Chlubek |
Blood Purification | 2007 |
|
Inflammation in the Pathogenesis of Chronic Diseases
RE Harris, R Bittman, D Dasgupta, H Engelhardt, L Flohe, H Herrmann, A Holzenburg, HP Nasheuer, S Rottem, M Wyss, P Zwickl |
2007 | |
|
Platelet Interaction with Bioactive Lipids Formed by Mild Oxidation of Low-Density Lipoprotein
W Siess |
Pathophysiology of Haemostasis and Thrombosis | 2006 |
|
Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease
MH Shishehbor, R Zhang, H Medina, ML Brennan, DM Brennan, SG Ellis, EJ Topol, SL Hazen |
Free radical biology & medicine | 2006 |
|
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
S Tsimikas, JT Willerson, PM Ridker |
Journal of the American College of Cardiology | 2006 |
|
The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis
ET Yeh, BV Khan |
Journal of Thrombosis and Haemostasis | 2006 |
|
Rofecoxib Increases Susceptibility of Human LDL and Membrane Lipids to Oxidative Damage: A Mechanism of Cardiotoxicity
RP Mason, MF Walter, HP McNulty, SF Lockwood, J Byun, CA Day, RF Jacob |
Journal of Cardiovascular Pharmacology | 2006 |
|
Cardiovascular pharmacology and physiology of the isoprostanes
JL Cracowski, T Durand |
Fundamental and Clinical Pharmacology | 2006 |
|
Disparate patterns of age-related changes in lipid peroxidation in long-lived naked mole-rats and shorter-lived mice
B Andziak, R Buffenstein |
Aging Cell | 2006 |
|
Low-Density Lipoprotein-Lowering Medication and Platelet Function
P Ferroni, S Basili, F Santilli, G Davì |
Pathophysiology of Haemostasis and Thrombosis | 2006 |
|
Oxidative Biomarkers in the Diagnosis and Prognosis of Cardiovascular Disease
S Tsimikas |
The American Journal of Cardiology | 2006 |
|
Measures of Oxidative Stress
S Tsimikas |
Clinics in Laboratory Medicine | 2006 |
|
In Renal Transplanted Patients Inflammation and Oxidative Stress Are Interrelated
S Cottone, A Palermo, F Vaccaro, F Raspanti, B Buscemi, F Incalcaterra, G Cerasola |
Transplantation Proceedings | 2006 |
|
Active Metabolite of Atorvastatin Inhibits Membrane Cholesterol Domain Formation by an Antioxidant Mechanism
RP Mason, MF Walter, CA Day, RF Jacob |
The Journal of biological chemistry | 2006 |
|
Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Lipidomics: a global approach to lipid analysis in biological systems
AD Watson |
Journal of lipid research | 2006 |
|
Absence of 12/15 lipoxygenase reduces brain oxidative stress in apolipoprotein E-deficient mice
CM Chinnici, Y Yao, T Ding, CD Funk, D Praticò |
The American Journal of Pathology | 2005 |
|
Induction of endothelial cell apoptosis by lipid hydroperoxide-derived bifunctional electrophiles
W Jian, JS Arora, T Oe, VV Shuvaev, IA Blair |
Free radical biology & medicine | 2005 |
|
The role of alternative splicing and C-terminal amino acids in thromboxane receptor stabilization
F Valentin, JR Tippins, MC Field |
Biochemical and Biophysical Research Communications | 2005 |
|
F2-Isoprostanes as markers of oxidative stressin vivo: An overview
GL Milne, ES Musiek, JD Morrow |
Biomarkers | 2005 |
|
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis
JM Dogné, J Hanson, D Pratico |
Trends in Pharmacological Sciences | 2005 |
|
Effects of KR-32570, a new Na+/H+ exchanger inhibitor, on functional and metabolic impairments produced by global ischemia and reperfusion in the perfused rat heart
BH Lee, HW Seo, KY Yi, S Lee, S Lee, S Yoo |
European Journal of Pharmacology | 2005 |
|
Les isoprostanes, biomarqueurs de peroxydation lipidique chez l'homme. Partie 3 : biomarqueurs et médiateurs en physiologie et pathologie vasculaire
JL Cracowski, O Berdeaux, T Durand |
Pathologie Biologie | 2005 |
|
Effect of estrogen on coronary vasoconstriction in patients undergoing coronary angioplasty
TM Lee, TF Chou, CH Tsai |
International Journal of Cardiology | 2005 |
|
Release of Free F 2 -isoprostanes from Esterified Phospholipids Is Catalyzed by Intracellular and Plasma Platelet-activating Factor Acetylhydrolases
DM Stafforini, JR Sheller, TS Blackwell, A Sapirstein, FE Yull, TM McIntyre, JV Bonventre, SM Prescott, LJ Roberts |
The Journal of biological chemistry | 2005 |
|
The role of inflammation in atherothrombosis: implications for clinical practice
A Tedgui |
Vascular medicine (London, England) | 2005 |
|
Isoprostanes: markers and mediators of oxidative stress
P MONTUSCHI |
The FASEB Journal | 2004 |
|
Inflammatory and oxidative markers in atherosclerosis: Relationship to outcome
MH Shishehbor, SL Hazen |
Current Atherosclerosis Reports | 2004 |
|
Antioxidants and Prevention of Chronic Disease
JK Willcox, SL Ash, GL Catignani |
Critical Reviews in Food Science and Nutrition | 2004 |
|
Optimal suppression of thromboxane a2 formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor
D Kearney, A Byrne, P Crean, D Cox, DJ Fitzgerald |
Journal of the American College of Cardiology | 2004 |
|
Revascularization decreases 8-isoprostaglandin F2α excretion in chronic lower limb ischemia
P Rossi, A Riutta, P Kuukasjärvi, T Vehmas, I Mucha, JP Salenius |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2004 |
|
8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells
H Scholz, P Aukrust, JK Damas, S Tonstad, EL Sagen, SO Kolset, C Hall, A Yndestad, B Halvorsen |
European Journal of Clinical Investigation | 2004 |
|
Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs
MF Walter, RF Jacob, CA Day, R Dahlborg, Y Weng, RP Mason |
Atherosclerosis | 2004 |
|
Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F2α on human umbilical vein
FM Daray, AI Minvielle, S Puppo, RP Rothlin |
European Journal of Pharmacology | 2004 |
|
F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases
D Praticò, J Rokach, J Lawson, GA FitzGerald |
Chemistry and Physics of Lipids | 2004 |
|
Molecular pharmacology of isoprostanes in vascular smooth muscle
A Habib, KF Badr |
Chemistry and Physics of Lipids | 2004 |
|
Isoprostanes: an emerging role in vascular physiology and disease?
JL Cracowski |
Chemistry and Physics of Lipids | 2004 |
|
Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities
P Fabbi, G Ghigliotti, C Brunelli, M Balbi, P Spallarossa, P Rossettin, A Barsotti, P Odetti, S Garibaldi |
Journal of Laboratory and Clinical Medicine | 2004 |
|
Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated
K Camphausen, C Ménard, M Sproull, E Goley, S Basu, CN Coleman |
International journal of radiation oncology, biology, physics | 2004 |
|
Bioactive lipids
S Pyne |
Bioactive lipids | 2004 |
|
Acute Coronary Syndromes, Third Edition: Pathoanatomical and Biomechanical Considerations
O Frøbert, HH Hansen, E Falk |
Acute Coronary Syndromes, Third Edition | 2004 |
|
ReviewIsoprostanes: Novel Bioactive Products of Lipid Peroxidation
S Basu |
Free Radical Research | 2004 |
|
Role of Oxidative Modifications in Atherosclerosis
R Stocker, JF Keaney |
Physiological reviews | 2004 |
|
Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development
A Ravandi, S Babaei, R Leung, JC Monge, G Hoppe, H Hoff, H Kamido, A Kuksis |
Lipids | 2004 |
|
Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E–deficient mice independently of effects on lipid peroxidation
E Waddington, IB Puddey, KD Croft |
The American journal of clinical nutrition | 2004 |
|
Vasodilatory and Electrophysiological Actions of 8-iso-Prostaglandin E 2 in Porcine Coronary Artery
Y Zhang, T Tazzeo, S Hirota, LJ Janssen |
The Journal of pharmacology and experimental therapeutics | 2003 |
|
The effects of tobacco smoke on the homocysteine level?a risk factor of atherosclerosis
A Sobczak |
Addiction Biology | 2003 |
|
Improvement of vascular function by chronic administration of a cyclo-oxygenase inhibitor in cholesterol-fed rabbits
S Srisawat, L Phivthong-ngam, S Unchern, U Chantharaksri, P Govitrapong, Y Sanvarinda |
Clinical and Experimental Pharmacology and Physiology | 2003 |
|
Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles
O Morel, L Jesel, B Hugel, MP Douchet, M Zupan, M Chauvin, JM Freyssinet, F Toti |
Journal of Thrombosis and Haemostasis | 2003 |
|
Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates
EI Waddington, KD Croft, K Sienuarine, B Latham, IB Puddey |
Atherosclerosis | 2003 |
|
Application of Gas Chromatography-Mass Spectrometry for Analysis of Isoprostanes: Their Role in Cardiovascular Disease
E Schwedhelm, RH Böger |
Clinical Chemistry and Laboratory Medicine | 2003 |
|
Augmented PLA2Activity in Pre-eclamptic Decidual Tissue—A Key Player in the Pathophysiology of ‘Acute Atherosis’ in Pre-eclampsia?
AC Staff, T Ranheim, B Halvorsen |
Placenta | 2003 |
|
AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients
V Witko-Sarsat, V Gausson, AT Nguyen, M Touam, T Drueke, F Santangelo, B Descamps-Latscha |
Kidney International | 2003 |
|
Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients
B Ferraro, F Galli, B Frei, E Kingdon, F Canestrari, C Rice-Evans, U Buoncristiani, A Davenport, KP Moore |
Kidney International | 2003 |
|
Fluvastatin Increases LDL Particle Size and Reduces Oxidative Stress in Patients with Hyperlipidemia
G Yoshino, T Hirano, T Kazumi, M Takemoto, N Ohashi |
Journal of Atherosclerosis and Thrombosis | 2003 |
|
PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress
M Christofidou-Solomidou, A Scherpereel, R Wiewrodt, K Ng, T Sweitzer, E Arguiri, V Shuvaev, CC Solomides, SM Albelda, VR Muzykantov |
American journal of physiology. Lung cellular and molecular physiology | 2003 |
|
Role of Monocytes in Atherogenesis
B Østerud, E Bjørklid |
Physiological reviews | 2003 |
|
Normal and oxidized low density lipoproteins accumulate deep in physiologically thickened intima of human coronary arteries
M Fukuchi, J Watanabe, K Kumagai, S Baba, T Shinozaki, M Miura, Y Kagaya, K Shirato |
Laboratory Investigation | 2002 |
|
Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis
JM Upston, X Niu, AJ Brown, R Mashima, H Wang, R Senthilmohan, AJ Kettle, RT Dean, R Stocker |
The American Journal of Pathology | 2002 |
|
Current Protocols in Toxicology
NG Abraham, SK Shenouda, A Goodman |
Current Protocols in Toxicology | 2002 |
|
Oxidative stress, alpha-tocopherol therapy, and atherosclerosis
A Harris, S Devaraj, I Jialal |
Current Atherosclerosis Reports | 2002 |
|
The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein
S Marlière, JL Cracowski, T Durand, O Chavanon, J Bessard, A Guy, F Stanke-Labesque, JC Rossi, G Bessard |
British Journal of Pharmacology | 2002 |
|
Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration
M Christofidou-Solomidou, S Kennel, A Scherpereel, R Wiewrodt, CC Solomides, GG Pietra, JC Murciano, SA Shah, H Ischiropoulos, SM Albelda, VR Muzykantov |
The American Journal of Pathology | 2002 |
|
Alteration of a macrophages inflammatory protein-related protein-2 (MRP-2) response by high fat and cholesterol diet in mice
R Yu, JS Park, T Kawada, BS Kwon |
Life Sciences | 2002 |
|
Lipid oxidation products and atherosclerosis
J Berliner |
Vascular Pharmacology | 2002 |
|
Advances in Cell Aging and Gerontology
T Fülöp, K Hirokawa, G Dupuis, A Larbi, G Pawelec |
Advances in Cell Aging and Gerontology | 2002 |
|
Derivatization of F2-isoprostanes with 1-pyrenyldiazomethane and their subsequent determination by fluorescence high-performance liquid chromatography
VB Ritov, DE Kelley, VE Kagan |
Analytical Biochemistry | 2002 |
|
Greater oxidative stress in healthy young men compared with premenopausal women
T Ide, H Tsutsui, N Ohashi, S Hayashidani, N Suematsu, M Tsuchihashi, H Tamai, A Takeshita |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
|
Similarity in the distribution of F 2 -isoprostanes in the lipid subfractions of atherosclerotic plaque and in vitro oxidised low density lipoprotein
EI Waddington, IB Puddey, TA Mori, KD Croft |
Redox Report | 2002 |
|
Receptors and signaling pathway underlying relaxations to isoprostanes in canine and porcine airway smooth muscle
A Catalli, D Zhang, LJ Janssen |
American journal of physiology. Lung cellular and molecular physiology | 2002 |
|
Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial
HY Huang, LJ Appel, KD Croft, ER Miller, TA Mori, IB Puddey |
The American journal of clinical nutrition | 2002 |
|
Vitamin E Oxidation in Human Atherosclerotic Lesions
AC Terentis, SR Thomas, JA Burr, DC Liebler, R Stocker |
Circulation research | 2002 |
|
β 2 Integrin-Dependent Neutrophil Adhesion Induced by Minimally Modified Low-Density Lipoproteins Is Mainly Mediated by F 2 -Isoprostanes
L Fontana, C Giagulli, L Cominacini, AF Pasini, P Minuz, A Lechi, A Sala, C Laudanna |
Circulation | 2002 |
|
Heme Oxygenase in Biology and Medicine
NG Abraham |
2002 | |
|
Lipid peroxidation and platelet activation in murine atherosclerosis
T Cyrus, LX Tang, J Rokach, GA FitzGerald, D Praticò |
Circulation | 2001 |
|
Isoprostane levels in lipids extracted from atherosclerotic arteries of nonhuman primates
MJ Thomas, Q Chen, MG Sorci-Thomas, LL Rudel |
Free radical biology & medicine | 2001 |
|
Handbook of Antioxidants
K Meissner, W Siems, O Sommerburg, M Leichsenring |
Handbook of Antioxidants | 2001 |
|
Urinary F2-isoprostanes formation in kidney transplantation
JL Cracowski, C Souvignet, N Quirin, X Grosbois, F Bayle, F Stanke-Labesque, P Vialtel, G Bessard |
Clinical Transplantation | 2001 |
|
The oxidant stress hypothesis of atherogenesis
L Iuliano |
Lipids | 2001 |
|
Measures of oxidative stress in heterozygous familial hypercholesterolaemia
J Nourooz-Zadeh |
Atherosclerosis | 2001 |
|
Formation of Isoprostanes in Children with Type IIa Hypercholesterolemia
JL Cracowski, D Ploin, J Bessard, JP Baguet, F Stanke-Labesque, JM Mallion, M Bost, G Bessard |
Journal of Cardiovascular Pharmacology | 2001 |
|
Transcardiac 8-iso-prostaglandin F2 αgeneration from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress
Y Kijima, K Hashimura, Y Matsu-ura, Y Kato, T Yasuda, T Ueda, Y Orita, M Fukunaga |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2001 |
|
6-oxo-PGF1 αand 8-epi-PGF2 αin the arterial wall layers of various species: a comparison between intact and atherosclerotic areas
A Oguogho, H Kritz, O Wagner, H Sinzinger |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2001 |
|
Atherosclerosis and Autoimmunity
EC Lau |
Atherosclerosis and Autoimmunity | 2001 |
|
Identification and Quantitation of Unique Fatty Acid Oxidation Products in Human Atherosclerotic Plaque Using High-Performance Liquid Chromatography
E Waddington, K Sienuarine, I Puddey, K Croft |
Analytical Biochemistry | 2001 |
|
Environmental Stressors in Health and Disease
B Halliwell |
Environmental Stressors in Health and Disease | 2001 |
|
Increased F 2 Isoprostanes in the Acute Chest Syndrome of Sickle Cell Disease as a Marker of Oxidative Stress
ES Klings, BW Christman, JA McCLUNG, AF Stucchi, LI McMAHON, M Brauer, HW Farber |
American journal of respiratory and critical care medicine | 2001 |
|
No evidence for lipid peroxidation in severe preeclampsia
CL Regan, RJ Levine, DD Baird, MG Ewell, KL Martz, BM Sibai, J Rokach, JA Lawson, GA FitzGerald |
American Journal of Obstetrics and Gynecology | 2001 |
|
Bio-Assays for Oxidative Stress Status
H Togashi, H Shinzawa, T Matsuo, Y Takeda, T Takahashi, M Aoyama, K Oikawa, H Kamada |
Bio-Assays for Oxidative Stress Status | 2001 |
|
Role of oxidized low-density lipoprotein in the atherosclerosis of uremia
TB Drüeke, TN Khoa, ZA Massy, V Witko-Sarsat, B Lacour, B Descamps-Latscha |
Kidney International | 2001 |
|
Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men
J Kaikkonen, E Porkkala-Sarataho, JD Morrow, LJ Roberts, K Nyyssönen, R Salonen, TP Tuomainen, U Ristonmaa, HE Poulsen, JT Salonen |
Free Radical Research | 2001 |
|
α-Tocopherol and Atherosclerosis
N Kaul, S Devaraj, I Jialal |
Experimental biology and medicine (Maywood, N.J.) | 2001 |
|
Isoprostanes: an overview and putative roles in pulmonary pathophysiology
LJ Janssen |
American journal of physiology. Lung cellular and molecular physiology | 2001 |
|
Interactions Between Nitric Oxide and Lipid Oxidation Pathways: Implications for Vascular Disease
VB ODonnell, BA Freeman |
Circulation research | 2001 |
|
8-Iso-PGF 2α Induces β 2 -Integrin–Mediated Rapid Adhesion of Human Polymorphonuclear Neutrophils: A Link Between Oxidative Stress and Ischemia/Reperfusion Injury
L Fontana, C Giagulli, P Minuz, A Lechi, C Laudanna |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
|
Dietary Cosupplementation With Vitamin E and Coenzyme Q 10 Inhibits Atherosclerosis in Apolipoprotein E Gene Knockout Mice
SR Thomas, SB Leichtweis, K Pettersson, KD Croft, TA Mori, AJ Brown, R Stocker |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
|
Twenty-First Century Phox: Not Yet Ready for Widespread Screening
AS Whitehead, GA FitzGerald |
Circulation | 2001 |
|
Constitutive and Inducible Expression of Cyp1a1 and Cyp1b1 in Vascular Smooth Muscle Cells: Role of the Ahr bHLH/PAS Transcription Factor
JK Kerzee, KS Ramos |
Circulation research | 2001 |
|
An intensive phenotyping study to enable the future examination of genetic influences on hypertension-associated cardiovascular disease
A Stanton, D Fitzgerald, A Hughes, J Mayet, E OBrien, NR Poulter, PS Sever, D Shields, S Thom |
Journal of Human Hypertension | 2001 |
|
The isoprostane 8‐iso‐PGF 2α stimulates endothelial cells to bind monocytes: difference to thromboxane‐mediated endothelial activation
N Leitinger, J Huber, C Rizza, D Mechtcheriakova, V Bochkov, Y Koshelnick, JA Berliner, BR Binder |
The FASEB Journal | 2001 |
|
A dimeric two‐component receiver domain inhibits the σ54‐dependent ATPase in DctD
M Meyer, S Park, L Zeringue, M Staley, M McKinstry, RI Kaufman, H Zhang, D Yan, N Yennawar, H Yennawar, GK Farber, BT Nixon |
The FASEB Journal | 2001 |
|
Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver
GK Marathe, KA Harrison, LJ Roberts, JD Morrow, RC Murphy, LW Tjoelker, SM Prescott, GA Zimmerman, TM McIntyre |
Journal of lipid research | 2001 |
|
Formation of 8-iso-PGF2αand thromboxane A2by stimulation with several activators of phospholipase A2in the isolated human umbilical vein
W Sametz, K Hummer, M Butter, R Wintersteiger, H Juan |
British Journal of Pharmacology | 2000 |
|
Isoprostanes: Generation, Pharmacology, and Roles in Free-radical-mediated Effects in the Lung
LJ Janssen |
Pulmonary Pharmacology & Therapeutics | 2000 |
|
LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2α
A Oguogho, A Ferlitsch, H Sinzinger |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2000 |
|
Measurement of F2-isoprostanes as an index of oxidative stress in vivo
LJ Roberts, JD Morrow |
Free radical biology & medicine | 2000 |
|
Indices of lipid peroxidation in vivo: strengths and limitations
EA Meagher, GA FitzGerald |
Free radical biology & medicine | 2000 |
|
Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants
GG Duthie, SJ Duthie, JA Kyle |
Nutrition Research Reviews | 2000 |
|
Role of activated protein C in Helicobacter pylori-associated gastritis
S Oka, EC Gabazza, Y Taguchi, M Yamaguchi, S Nakashima, K Suzuki, Y Adachi, I Imoto |
Infection and immunity | 2000 |
|
Radioimmunological measurement of F2-isoprostanes after hydrolysis of lipids in tissues
E Södergren, B Vessby, S Basu |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2000 |
|
Human internal mammary artery contraction by isoprostaglandin F2α type-III (8-iso-prostaglandin F2α)
JL Cracowski, F Stanke-Labesque, P Devillier, O Chavanon, M Hunt, C Souvignet, G Bessard |
European Journal of Pharmacology | 2000 |
|
The steady-state levels of oxidative DNA damage and of lipid peroxidation (F 2 -isoprostanes) are not correlated in healthy human subjects
T England, E Beatty, A Rehman, J Nourooz-Zadeh, P Pereira, J O'Reilly, H Wiseman, C Geissler, B Halliwell |
Free Radical Research | 2000 |
|
Specific Analysis in Plasma and Urine of 2,3-Dinor-5,6-dihydro-isoprostane F 2α -III, a Metabolite of Isoprostane F 2α -III and an Oxidation Product of γ-Linolenic Acid
A Burke, JA Lawson, EA Meagher, J Rokach, GA FitzGerald |
The Journal of biological chemistry | 2000 |
|
Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
O Belton, D Byrne, D Kearney, A Leahy, DJ Fitzgerald |
Circulation | 2000 |
|
Radiolabeled Native Low-Density Lipoprotein Injected Into Patients With Carotid Stenosis Accumulates in Macrophages of Atherosclerotic Plaque: Effect of Vitamin E Supplementation
L Iuliano, A Mauriello, E Sbarigia, LG Spagnoli, F Violi |
Circulation | 2000 |
|
Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable Angina
F Cipollone, G Ciabattoni, P Patrignani, M Pasquale, DD Gregorio, T Bucciarelli, G Davı̀, F Cuccurullo, C Patrono |
Circulation | 2000 |
|
Multiple Organ Failure
AE Baue, E Faist, DE Fry |
2000 | |
|
Oxidative Stress and Vascular Disease
JF Keaney |
2000 | |
|
Moderate Alcohol Consumption and Cardiovascular Disease
R Paoletti, AL Klatsky, A Poli, S Zakhari |
2000 | |
|
The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis
Z Mallat, T Nakamura, J Ohan, G Lesèche, A Tedgui, J Maclouf, RC Murphy |
Journal of Clinical Investigation | 1999 |
|
Alcohol-induced generation of lipid peroxidation products in humans
EA Meagher, OP Barry, A Burke, MR Lucey, JA Lawson, J Rokach, GA FitzGerald |
Journal of Clinical Investigation | 1999 |
|
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
T Cyrus, JL Witztum, DJ Rader, R Tangirala, S Fazio, MF Linton, CD Funk |
Journal of Clinical Investigation | 1999 |
|
F2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo
D Praticò |
Atherosclerosis | 1999 |
|
Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue
L Iuliano, JZ Pedersen, C Camastra, V Bello, S Ceccarelli, F Violi |
Free radical biology & medicine | 1999 |
|
Influence of isoprostanes on vasoconstrictor effects of noradrenaline and angiotensin II
W Sametz, T Grobuschek, S Hammer-Kogler, H Juan, R Wintersteiger |
European Journal of Pharmacology | 1999 |
|
Isoflavonoids do not inhibit in vivo lipid peroxidation in subjects with high-normal blood pressure
JM Hodgson, IB Puddey, KD Croft, TA Mori, J Rivera, LJ Beilin |
Atherosclerosis | 1999 |
|
Time Course of Free Radical Production After Primary Coronary Angioplasty for Acute Myocardial Infarction and the Effect of Vitamin C
W Guan, T Osanai, T Kamada, H Ishizaka, H Hanada, K Okumura |
Japanese Circulation Journal | 1999 |
|
The isoprostanes: Novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid
T Liu, A Stern, LJ Roberts, JD Morrow |
Journal of Biomedical Science | 1999 |
|
Macrophage Foam Cell Formation During Early Atherogenesis Is Determined by the Balance Between Pro-Oxidants and Anti-Oxidants in Arterial Cells and Blood Lipoproteins
M Aviram |
Antioxidants & Redox Signaling | 1999 |
|
Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine
H Li, JA Lawson, M Reilly, M Adiyaman, SW Hwang, J Rokach, GA FitzGerald |
Proceedings of the National Academy of Sciences | 1999 |
|
Establishing the Significance and Optimal Intake of Dietary Antioxidants: The Biomarker Concept
B Halliwell |
Nutrition Reviews | 1999 |
|
Vascular effects of isoprostanes after endothelial damage
W Sametz, S Prasthofer, R Wintersteiger, J Juan |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1999 |
|
Elevated level of free 8-iso-prostaglandin F2α in the decidua basalis of women with preeclampsia
AC Staff, B Halvorsen, T Ranheim, T Henriksen |
American Journal of Obstetrics and Gynecology | 1999 |
|
Brains of Aged Apolipoprotein E-Deficient Mice Have Increased Levels of F2-Isoprostanes, In Vivo Markers of Lipid Peroxidation
D Praticò, J Rokach, RK Tangirala |
Journal of Neurochemistry | 1999 |
|
An Improved Method for the Measurement of Urinary and Plasma F2-Isoprostanes Using Gas Chromatography–Mass Spectrometry
TA Mori, KD Croft, IB Puddey, LJ Beilin |
Analytical Biochemistry | 1999 |
|
Structural Identification of a Novel Pro-inflammatory Epoxyisoprostane Phospholipid in Mildly Oxidized Low Density Lipoprotein
AD Watson, G Subbanagounder, DS Welsbie, KF Faull, M Navab, ME Jung, AM Fogelman, JA Berliner |
The Journal of biological chemistry | 1999 |
|
Isoprostanes: Formation, Analysis and Use As Indices of Lipid Peroxidation in Vivo
JA Lawson, J Rokach, GA FitzGerald |
The Journal of biological chemistry | 1999 |
|
Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans
AC Carr, B Frei |
The American journal of clinical nutrition | 1999 |
|
Does vitamin C act as a pro-oxidant under physiological conditions?
A Carr, B Frei |
The FASEB Journal | 1999 |
|
Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels
S Voutilainen, JD Morrow, LJ Roberts, G Alfthan, H Alho, K Nyyssönen, JT Salonen |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
|
Molecular and Cellular Basis of Inflammation
CN Serhan, PA Ward |
1999 | |
|
Periodontitis-atherosclerosis syndrome: an expanded model of pathogenesis
S Offenbacher, PN Madianos, CM Champagne, JH Southerland, DW Paquette, RC Williams, G Slade, JD Beck |
Journal of Periodontal Research | 1999 |
|
Leukocytes Utilize Myeloperoxidase-Generated Nitrating Intermediates as Physiological Catalysts for the Generation of Biologically Active Oxidized Lipids and Sterols in Serum
D Schmitt, Z Shen, R Zhang, SM Colles, W Wu, RG Salomon, Y Chen, GM Chisolm, SL Hazen |
Biochemistry | 1999 |
|
Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules
JP Eiserich, RP Patel, VB O’Donnell |
Molecular Aspects of Medicine | 1998 |
|
Oxidized phospholipids and isoprostanes in atherosclerosis
JL Witztum, JA Berliner |
Current Opinion in Lipidology | 1998 |
|
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice
D Praticò, RK Tangirala, DJ Rader, J Rokach, GA FitzGerald |
Nature Medicine | 1998 |
|
Oxidative injury in the nervous system
N Delanty, MA Dichter |
Acta Neurologica Scandinavica | 1998 |
|
Total Synthesis of 17,17,18,18-d4-iPF2α-VI and Quantification of iPF2α-VI in Human Urine by Gas Chromatography/Mass Spectrometry
M Adiyaman, JA Lawson, SP Khanapure, GA FitzGerald, J Rokach |
Analytical Biochemistry | 1998 |
|
Increased formation of distinct F2 isoprostanes in hypercholesterolemia
MP Reilly, D Praticò, N Delanty, G DiMinno, E Tremoli, D Rader, S Kapoor, J Rokach, J Lawson, GA FitzGerald |
Circulation | 1998 |
|
Chronic Obstructive Pulmonary Disease Is Associated with an Increase in Urinary Levels of Isoprostane F 2 α -III, an Index of Oxidant Stress
D Praticò, S Basili, M Vieri, C Cordova, F Violi, GA Fitzgerald |
American journal of respiratory and critical care medicine | 1998 |
|
Identification of Two Major F 2 Isoprostanes, 8,12-Iso- and 5- epi -8,12-Iso-isoprostane F 2α -VI, in Human Urine
JA Lawson, H Li, J Rokach, M Adiyaman, SW Hwang, SP Khanapure, GA FitzGerald |
The Journal of biological chemistry | 1998 |
|
Eicosanoids and Isoeicosanoids: Indices of Cellular Function and Oxidant Stress
MP Reilly, JA Lawson, GA FitzGerald |
The Journal of nutrition | 1998 |
|
Increased F 2 -isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo
D Praticò, V M.-Y.Lee, JQ Trojanowski, J Rokach, GA Fitzgerald |
The FASEB Journal | 1998 |
|
To E or Not To E—How Do We Tell?
JL Witztum |
Circulation | 1998 |
|
Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages
G Camejo, C Halberg, A Manschik-Lundin, E Hurt-Camejo, B Rosengren, H Olsson, GI Hansson, GB Forsberg, B Ylhen |
Journal of lipid research | 1998 |
|
Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
C Patrono, GA FitzGerald |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
|
Increased Formation of the Isoprostanes IPF 2α -I and 8-Epi-Prostaglandin F 2α in Acute Coronary Angioplasty: Evidence for Oxidant Stress During Coronary Reperfusion in Humans
MP Reilly, N Delanty, L Roy, J Rokach, PO Callaghan, P Crean, JA Lawson, GA FitzGerald |
Circulation | 1997 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)